Telethon Kids Institute, University of Western Australia, Subiaco, Western Australia, Australia.
Phylogica Pty Ltd, Subiaco, Western Australia, Australia.
Sci Rep. 2018 Aug 22;8(1):12538. doi: 10.1038/s41598-018-30790-2.
Cell penetrating peptides (CPPs) offer great potential to deliver therapeutic molecules to previously inaccessible intracellular targets. However, many CPPs are inefficient and often leave their attached cargo stranded in the cell's endosome. We report a versatile platform for the isolation of peptides delivering a wide range of cargos into the cytoplasm of cells. We used this screening platform to identify multiple "Phylomer" CPPs, derived from bacterial and viral genomes. These peptides are amenable to conventional sequence optimization and engineering approaches for cell targeting and half-life extension. We demonstrate potent, functional delivery of protein, peptide, and nucleic acid analog cargos into cells using Phylomer CPPs. We validate in vivo activity in the cytoplasm, through successful transport of an oligonucleotide therapeutic fused to a Phylomer CPP in a disease model for Duchenne's muscular dystrophy. This report thus establishes a discovery platform for identifying novel, functional CPPs to expand the delivery landscape of druggable intracellular targets for biological therapeutics.
细胞穿透肽(CPPs)为将治疗分子递送至以前无法到达的细胞内靶标提供了巨大的潜力。然而,许多 CPP 效率低下,并且经常导致其附着的货物滞留在细胞的内体中。我们报告了一种用于分离肽的多功能平台,这些肽可以将广泛的货物递送到细胞的细胞质中。我们使用该筛选平台鉴定了多种源自细菌和病毒基因组的“Phylomer”CPP。这些肽可通过常规的序列优化和工程方法进行细胞靶向和半衰期延长。我们使用 Phylomer CPP 证明了蛋白质、肽和核酸类似物货物的有效功能递送至细胞中。我们通过将与 Phylomer CPP 融合的寡核苷酸治疗药物在杜氏肌营养不良症的疾病模型中成功运输到细胞质中来验证体内活性。因此,本报告建立了一个发现平台,用于鉴定新型功能 CPP,以扩展可用于生物治疗的可用药细胞内靶标的递药范围。